| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5877484 | The American Journal of Medicine | 2016 | 15 Pages |
Abstract
The “real world” effectiveness and safety of rivaroxaban is similar for venous thromboembolism patients with and without active malignancy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Dalene M. APRN, CNP, Rayya A. DO, Robert D. MD, Charles L. MD, Aneel A. MD, Teresa R. PA-C, Alissa A. RN, Michelle M. RN, Waldemar E. MD,